145 related articles for article (PubMed ID: 33626044)
21. Retrospective Analysis of Concurrent Chemoradiation with Triweekly Cisplatin plus 5-Fluorouracil Versus Weekly Cisplatin in Cervical Cancer.
Sonoda K; Yahata H; Ichinoe A; Okugawa K; Kaneki E; Kawano Y; Kenjo H; Ohgami T; Yagi H; Ohga S; Asai K; Nakamura K; Honda H; Kato K
Anticancer Res; 2015 Jun; 35(6):3447-54. PubMed ID: 26026109
[TBL] [Abstract][Full Text] [Related]
22. Renal function and risk factors for renal disease for patients receiving HIV pre-exposure prophylaxis at an inner metropolitan health service.
Drak D; Barratt H; Templeton DJ; O'Connor CC; Gracey DM
PLoS One; 2019; 14(1):e0210106. PubMed ID: 30653509
[TBL] [Abstract][Full Text] [Related]
23. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa.
Kamkuemah M; Kaplan R; Bekker LG; Little F; Myer L
Trop Med Int Health; 2015 Apr; 20(4):518-26. PubMed ID: 25442109
[TBL] [Abstract][Full Text] [Related]
24. The Efficacy of Palonosetron Plus Dexamethasone in Preventing Chemoradiotherapy-induced Nausea and Emesis in Patients Receiving Daily Low-dose Cisplatin-based Concurrent Chemoradiotherapy for Uterine Cervical Cancer: A Phase II Study.
Mitsuhashi A; Usui H; Nishikimi K; Yamamoto N; Hanawa S; Tate S; Watanabe-Nemoto M; Uno T; Shozu M
Am J Clin Oncol; 2017 Apr; 40(2):118-121. PubMed ID: 25144265
[TBL] [Abstract][Full Text] [Related]
25. Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study.
Domingo P; Suarez-Lozano I; Gutierrez F; Estrada V; Knobel H; Palacios R; Antela A; Blanco JR; Fulladosa X;
Nefrologia (Engl Ed); 2019; 39(5):497-505. PubMed ID: 31027896
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
Fujiwara M; Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Sumida I; Hayashi K; Kimura T; Ogawa K
J Radiat Res; 2015 Mar; 56(2):305-14. PubMed ID: 25428244
[TBL] [Abstract][Full Text] [Related]
27. Renal function in a cohort of HIV-infected patients initiating antiretroviral therapy in an outpatient setting in Ethiopia.
Fiseha T; Gebreweld A
PLoS One; 2021; 16(1):e0245500. PubMed ID: 33481839
[TBL] [Abstract][Full Text] [Related]
28. Moderate renal dysfunction may not require a cisplatin dose reduction: a retrospective study of cancer patients with renal impairment.
Ogawa T; Niho S; Nagai S; Kojima T; Nishimura Y; Ohe Y; Kondo N; Yamaguchi T; Endo K; Izumi K; Minami H
Int J Clin Oncol; 2013 Dec; 18(6):977-82. PubMed ID: 23053402
[TBL] [Abstract][Full Text] [Related]
29. Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin.
van der Vorst MJDL; Neefjes ECW; Toffoli EC; Oosterling-Jansen JEW; Vergeer MR; Leemans CR; Kooistra MP; Voortman J; Verheul HMW
BMC Cancer; 2019 Nov; 19(1):1066. PubMed ID: 31703649
[TBL] [Abstract][Full Text] [Related]
30. Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy.
Sun W; Wang T; Shi F; Wang J; Wang J; Hui B; Zhang Y; Lu J; Chen H; Liu Z
BMC Cancer; 2015 May; 15():353. PubMed ID: 25935645
[TBL] [Abstract][Full Text] [Related]
31. Effects of aging, baseline renal function and stage of HIV infection on post-treatment changes in renal function among HIV-infected patients: a retrospective cohort study.
Ding Y; Duan S; Ye R; Yao S; Cao D; Yang Y; Wang J; Shi Y; Zhang Y; Li P; Xu Y; Wei H; Yin C; Liu X; He N
HIV Med; 2019 Oct; 20(9):591-600. PubMed ID: 31274235
[TBL] [Abstract][Full Text] [Related]
32. Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting.
Grover S; Bvochora-Nsingo M; Yeager A; Chiyapo S; Bhatia R; MacDuffie E; Puri P; Balang D; Ratcliffe S; Narasimhamurthy M; Gwangwava E; Tsietso S; Kayembe MKA; Ramogola-Masire D; Dryden-Peterson S; Mahantshetty U; Viswanathan AN; Zetola NM; Lin LL
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):201-210. PubMed ID: 29619965
[TBL] [Abstract][Full Text] [Related]
33. Chemoradiation in Stage IIIB Cancer of the Uterine Cervix: A Review of the Zimbabwean Experience.
Nyamhunga A; Ndlovu N; Kadzatsa W; Morse GD; Maponga CC
JCO Glob Oncol; 2020 Oct; 6():1554-1564. PubMed ID: 33064579
[TBL] [Abstract][Full Text] [Related]
34. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
[TBL] [Abstract][Full Text] [Related]
35. Radical Hysterectomy Plus Concurrent Chemoradiation/Radiation Therapy Is Negatively Associated With Return to Work in Patients With Cervical Cancer.
Nakamura K; Masuyama H; Ida N; Haruma T; Kusumoto T; Seki N; Hiramatsu Y
Int J Gynecol Cancer; 2017 Jan; 27(1):117-122. PubMed ID: 27668396
[TBL] [Abstract][Full Text] [Related]
36. Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients.
Huang YS; Chan CK; Tsai MS; Lee KY; Lin SW; Chang SY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2017 Oct; 50(5):595-603. PubMed ID: 26514942
[TBL] [Abstract][Full Text] [Related]
37. Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting.
Manosuthi W; Prasithsirikul W; Tantanathip P; Chimsuntorn S; Nilkamhang S; Sungkanuparph S
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):643-50. PubMed ID: 21706942
[TBL] [Abstract][Full Text] [Related]
38. Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy.
Faig J; Haughton M; Taylor RC; D'Agostino RB; Whelen MJ; Porosnicu Rodriguez KA; Bonomi M; Murea M; Porosnicu M
Am J Clin Oncol; 2018 May; 41(5):432-440. PubMed ID: 27281266
[TBL] [Abstract][Full Text] [Related]
39. Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir.
Yilma D; Abdissa A; Kæstel P; Tesfaye M; Olsen MF; Girma T; Ritz C; Friis H; Andersen ÅB; Kirk O
BMC Infect Dis; 2020 Aug; 20(1):582. PubMed ID: 32762646
[TBL] [Abstract][Full Text] [Related]
40. Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer.
Abu-Rustum NR; Lee S; Correa A; Massad LS
Gynecol Oncol; 2001 Apr; 81(1):88-91. PubMed ID: 11277656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
